63491-88-3 Usage
Uses
Used in Pharmaceutical Industry:
3-Bromo-4-hydroxybenzylamine is used as a building block for the synthesis of various pharmaceutical compounds due to its unique structure and reactivity, contributing to the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical field, 3-Bromo-4-hydroxybenzylamine is utilized as a key intermediate in the production of agrochemical compounds, playing a crucial role in the synthesis of pesticides and other agricultural chemicals to improve crop protection and yield.
Used in Medicinal Chemistry Research:
3-Bromo-4-hydroxybenzylamine is employed as a valuable intermediate in medicinal chemistry research, where it aids in the development of biologically active molecules with potential applications in treating various diseases and conditions.
Used in Anti-Cancer Drug Development:
This chemical compound is used as a precursor in the development of anti-cancer drugs, leveraging its structural properties to create molecules that can target and combat cancer cells effectively.
Used in Synthesis of Natural Products:
3-Bromo-4-hydroxybenzylamine has the potential to be used in the synthesis of various natural products, contributing to the creation of novel compounds with potential applications in the pharmaceutical, agrochemical, and related industries.
Check Digit Verification of cas no
The CAS Registry Mumber 63491-88-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,3,4,9 and 1 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 63491-88:
(7*6)+(6*3)+(5*4)+(4*9)+(3*1)+(2*8)+(1*8)=143
143 % 10 = 3
So 63491-88-3 is a valid CAS Registry Number.
InChI:InChI=1/C7H8BrNO/c8-6-3-5(4-9)1-2-7(6)10/h1-3,10H,4,9H2
63491-88-3Relevant academic research and scientific papers
Arylalkylamine vanadium (V) salts for the treatment and/or prevention of Diabetes mellitus
-
Page/Page column 19; 20, (2010/11/26)
This invention provides compounds of formula (IIA) and pharmaceutical compositions thereof, where M, a, b, and R1-R5 are as defined herein, for treating human type 1 and type 2 diabetes, particularly insulin-resistant diabetes. Pharmaceutical compositions comprising the compounds of formula (IIA) are also disclosed.
New efficient substrates for semicarbazide-sensitive amine oxidase/VAP-1 enzyme: Analysis by SARs and computational docking
Yraola, Francesc,García-Vicente, Silvia,Fernández-Recio, Juan,Albericio, Fernando,Zorzano, Antonio,Marti, Luc,Royo, Miriam
, p. 6197 - 6208 (2007/10/03)
Structure activity relationships for semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 (SSAO/VAP-1) were studied using a library of arylalkylamine substrates, with the aim of contributing to the discovery of more efficient SSAO substrates. Experimental data were contrasted with computational docking studies, thereby allowing us to examine the mechanism and substrate-binding affinity of SSAO and thus contribute to the discovery of more efficient SSAO substrates and provide a structural basis for their interactions. We also built a model of the mouse SSAO structure, which provides several structural rationales for interspecies differences in SSAO substrate selectivity and reveals new trends in SSAO substrate recognition. In this context, we identified novel efficient substrates for human SSAO that can be used as a lead for the discovery of antidiabetic agents.
